Group Structure
Bumrungrad Hospital Public Company Limited (the “Company”) operates a private hospital in Bangkok, providing services with an inpatient capacity of 580 beds and the ability to accommodate more than 5,500 outpatient visits per day. The Company offers comprehensive medical services covering specialized and complex conditions that require advanced expertise, supported by modern medical technology and innovation. All services are delivered under the care of a team of physicians and medical professionals with internationally recognized competencies, enabling the Company to serve both domestic and international patients.
Bumrungrad Hospital places strong emphasis on patient‑centered care and prioritizes clinical outcomes by benchmarking its performance against leading international medical institutions. This approach guides the continuous improvement of treatment quality, supported by ongoing investments in advanced technology, innovation, and medical research.
Bumrungrad International Hospital is the first hospital in Asia to receive international hospital accreditation from the Joint Commission International (JCI) of the United States. It is also the first hospital to receive Thai Hospital Accreditation (HA) and Advanced Hospital Accreditation (AHA), with continuous accreditation to the present.
In addition, the hospital is the first in the world to receive the GHA COVID‑19 Conformance Certification from the Global Healthcare Accreditation (GHA) organization, reflecting its effective management of the COVID‑19 situation. The hospital has also been accredited by the College of American Pathologists (CAP) for laboratory quality standards.
The hospital has been ranked by Newsweek and Statista as one of the World’s Best Hospitals and the Best Hospital in Thailand (World’s Best Hospitals 2025 – Thailand) for five consecutive years, and has also been recognized as one of the World’s Best Smart Hospitals.
The Company has additionally received the Best Company Performance Award (for companies with a market capitalization above THB 100 billion) for the third consecutive year at the SET Awards 2025, reflecting its strong business performance and commitment to good corporate governance.
* Click here to view large image
The Company has 11 subsidiaries, namely (1) Asia Global Health Limited, (2) Asia Global Research Company Limited, (3) Bumrungrad Health Network Company Limited (formerly known as Bumrungrad Personnel Development Center Company Limited), (4) Bumrungrad International Hospital Phuket Company Limited, (5) Bumrungrad Personnel Development and Training Center Company Limited, (6) Bumrungrad Services Company Limited, (7) Health Horizons Enterprises Pte. Ltd., (8) Life and Longevity Limited, (9) Ruenmongkol Company Limited, (10) VitalLife Corporation Limited, and (11) VitalLife Allianz Company Limited.
The Company also has seven indirect subsidiaries, namely (1) Bumrungrad Myanmar Company Limited (80%-owned through Bumrungrad Health Network Company Limited), (2) Bumrungrad Mongolia LLC (80%-owned through Bumrungrad Health Network Company Limited which acquired the shares from Health Horizons Enterprises Pte. Ltd. in 2023), (3) Bumrungrad Spine Network Company Limited (75%-owned through Bumrungrad Health Network Company Limited), (4) Keyoniq Health AG (100%-owned through Bumrungrad Health Network Company Limited) (formerly VitalLife Switzerland AG)), (5) Keyoniq Technologies AG (100%-owned through Bumrungrad Health Network Company Limited) (formerly Keyoniq Switzerland AG), (6) Lifestyletech Solution Company Limited (100%-owned through Bumrungrad Services Company Limited) (formerly P53 Life Sciences Company Limited), (7) Seoul Seniors Towers LLC (approx. 41%-owned with control as per its shareholding portion through Bumrungrad Health Network Company Limited and Bumrungrad Mongolia LLC).
The Company has two associated companies, namely (1) 50%-owned BB Health Venture Company Limited and (2) 50%-indirectly owned RAKxa Venture Company Limited through VitalLife Allianz Company Limited.
Details of subsidiaries, affiliated companies, and associated companies are as follows:
Asia Global Health Limited (“AGH”) incorporated incorporated in the Hong Kong Special Administrative Region of the People’s Republic of China, served as an entity supporting investments in medical and related businesses within the region. As the company was financially solvent and had ceased its business operations, it proceeded to apply for deregistration in accordance with Hong Kong regulations, which resulted in the company being dissolved without the need for liquidation. The deregistration became effective on 30 January 2029.
Asia Global Research Company Limited (“AGR”) is the provider of clinical research, both within Thailand and Southeast Asia. Acting as the contract research organization (CRO), AGR conducts research and provides drug R&D planning advice for pharmaceutical companies, medical equipment first, and other clinical research companies with the purpose of achieving quality and precise research outcomes and information. AGR also operates the Esperance Integrative Cancer Clinic, iConic drug store, and direct marketing.
Bumrungrad Health Network Company Limited (“BHN”) (previously Bumrungrad Personnel Development Center Co., Ltd.) is a company that focuses on investing in healthcare and related businesses, both domestic and overseas.
Bumrungrad International Hospital Phuket Company Limited ("BIHP") operates the services business of sanatorium.
Bumrungrad Myanmar Company Limited ("BM”) operates a private primary care and medical diagnostic services clinic in Myanmar.
Bumrungrad Mongolia LLC (“BML”) is a holding company registered in Mongolia, which supports the Company’s strategy for overseas investment in healthcare and related businesses.
Bumrungrad Personnel Development and Training Center Company Limited ("BPDTC”) is a personnel development and training company that focuses on improving and expanding the capabilities of clinical and healthcare services to the Company and affiliated companies only.
Bumrungrad Services Company Limited (“BS”) is a company that supports the strategy for referral services to both domestic and foreign patients and provides healthcare-related training services to non-affiliated companies.
Bumrungrad Spine Network Company Limited (“BSN”) is a company that provides consulting and management services to healthcare facilities.
Health Horizons Enterprises Pte. Ltd. (“HHE”) is a holding company registered in Singapore, which supports the Company’s strategy for overseas investment in healthcare and related businesses.
Keyoniq Health AG ("KYQH") was formerly known as Inovital International AG (“Inovital"). BHN acquired all the shares of Inovital and rebranded the company to VitalLife Switzerland AG (“VTLS”) in the third quarter of 2023. In 2024, VTLS changed its name to Keyoniq Health AG. KYQH offers and provides innovative, science-based medical treatment services and products aimed at predictive, preventive, revitalizing and regenerative care.
Keyoniq Technologies AG ("KYQT") is a research and development company that provides AI powered data centric software applications for the healthcare domain.
Life and Longevity Limited (“LLL”) incorporated in the Hong Kong Special Administrative Region of the People’s Republic of China, was established as a holding company for overseas investments. As the company was financially solvent and had ceased its business operations, it proceeded to apply for deregistration in accordance with Hong Kong regulations, which resulted in the company being dissolved without the need for liquidation. The deregistration became effective on 30 January 2029.
Lifestyletech Solution Company Limited ("LTS") (formerly P53 Life Sciences Co., Ltd. (“PLS”)) operates digital platform service business.
Ruenmongkol Company Limited (“RM”) owns the land on Sukhumvit Soi 1 (approximately 3-3-44.4 rai). The Company has built a car park building thereon and is currently constructing two additional buildings intended to serve as a sanatorium.
Seoul Seniors Towers LLC (“SST”) is a company that owns and operates Ulaanbaatar Songdo Hospital in Mongolia.
VitalLife Corporation Limited (“VitalLife”) is a pioneer in longevity medicine, integrating predictive, preventive, rejuvenating, and regenerative strategies for optimal healthy lifestyles. Vital Life brings together cutting-edge technologies to provide patients with the means to “Feel Younger, Look Better, and Live Longer”. Biomarker analysis, advanced supplementation, toxicity assessments, early detection, and regenerative medicine are key Vital Life analytics. VitalLife also operates a skin clinic and a direct marketing business selling organic cosmetic products as well.
VitalLife Allianz Company Limited (“VTLA”) is a company engaged in providing consultancy and management services for healthcare facilities.
BB Health Venture Company Limited ("BBHV") is a joint venture company formed by Bumrungrad Hospital Public Company Limited and BTS Group Holdings Public Company Limited. It engages in the business of sanatorium.
RAKxa Venture Co., Ltd. (“RAKxa”) is a joint venture company formed by VitalLife Allianz Company Limited and Rx Wellness Company Limited, a subsidiary of M.K. Real Estate Development Public Company Limited. It engages in the business of a wellness center, clinic and medical center, and rehabilitation center.